Semilinear canonical correlation applied to the measurement of the electroencephalographic effects of midazolam and flumazenil reversal

Anesthesiology

Volumn 84, Issue 3, 1996, Pages 510-519

  Schnider, Thomas W ^a,e   Minto, Charles F ^a   Fiset, Pierre ^a,b   Gregg, Keith M ^a,c   Shafer, Steven L ^a,c,d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c STANFORD UNIVERSITY   (United States)

^d VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^e Institut fur Anasthesie Kantonsspital Luzern   (Switzerland)

Author keywords

Monitoring: electroencephalographic analysis; Pharmacodynamics, benzodiazepines: flumazenil; midazolam; Statistical method: semilinear canonical correlation

Indexed keywords

FLUMAZENIL; MIDAZOLAM;

ADULT; ARTICLE; BETA RHYTHM; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG BLOOD LEVEL; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PRIORITY JOURNAL; SEDATION; STATISTICAL ANALYSIS;

ADULT; ANTI-ANXIETY AGENTS; ELECTROENCEPHALOGRAPHY; FLUMAZENIL; HUMANS; MIDAZOLAM; STATISTICS;

EID: 0029927768     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199603000-00004     Document Type: Article

References (15)

1. Greenblatt DJ, Ehrenberg BL, Gunderman J, Locniskar A, Scavone JM, Harmatz JS, Shader RI: Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam, and placebo. Clin Pharmacol Ther 1989; 45:356-65
2. Mandema JW, Danhof M: Electroencephalogram effect measures and relationships between pharmacokinetics and pharmacodynamics of centrally acting drugs. Clin Pharmacokinet 1992; 23:191-215
3. Breimer LT, Hennis PJ, Burm AG, Danhof M, Bovill JG, Spierdijk J, Vletter AA: Quantification of the EEG effect of midazolam by aperiodic analysis in volunteers. Pharmacokinetic/pharmacodynamic modelling. Clin Pharmacokinet 1990; 18:245-53
4. Buhrer M, Maitre PO, Hung O, Stanski DR: Electroencephalographic effects of benzodiazepines. I. Choosing an electroencephalographic parameter to measure the effect of midazolam on the central nervous system. Clin Pharmacol Ther 1990; 48:544-54
5. Fiset P, Lemmens HL, Egan TE, Shafer SL, Stanski DR: Pharmacodynamic modeling of the electroencephalographic effects of flumazenil in healthy volunteers sedated with midazolam. Clin Pharmacol Ther 1995; 58:567-82
6. Gregg KM, Varvel JR, Shafer SL: Application of semilinear canonical correlation to the measurement of opioid drug effect. J Pharmacokinet Biopharm 1992; 20:611-35
7. Shafer SL, Varvel JR, Gronert GA: A comparison of parametric with semiparametric analysis of the concentration versus effect relationship of metocurine in dogs and pigs. J Pharmacokinet Biopharm 1989; 17:291-304
8. Sheiner LB, Stanski DR, Vozeh S, Miller RD, Ham J: Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clin Pharmacol Ther 1979; 25:358-71
9. Hull CJ, Van Beem HB, McLeod K, Sibbald A, Watson MJ: A pharmacodynamic model for pancuronium. Br J Anaesth 1978;50: 1113-23
10. Hill AV: The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves. J Physiol 1910;40: iv-vii
11. Klotz U, Ziegler G, Ludwig L, Reimann IW: Pharmacodynamic interaction between midazolam and a specific benzodiazephine antagonist in humans. J Clin Pharmacol 1985; 25:400-6
12. Gath I, Weidenfeld J, Collins GI, Hadad H: Electrophysiological aspects of benzodiazepine antagonists, Ro 15-1788 and Ro 15-3505. Br J Clin Pharmacol 1984; 18:541-7
13. Gambus PL, Gregg KM, Shafer SL: Validation of the alfentanil canonical univariate parameter as a measure of opioid effect on the electroencephalogram. ANESTHESIOLOGY 1995; 83:747-56
14. Mandema JW, Tukker E, Danhof M: In vivo characterization of the pharmacodynamic interaction of a benzodiazepine agonist and antagonist: midazolam and flumazenil. J Pharmacol Exp Ther 1992; 260:36-44
15. Mandema JW, Sansom LN, Dios-Vieitez MC, Hollander-Jansen M, Danhof M: Pharmacokinetic-pharmacodynamic modeling of the electroencephalographic effects of benzodiazepines. Correlation with receptor binding and anticonvulsant activity. J Pharmacol Exp Ther 1991; 257:472-8